+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review

FEATURED COMPANIES

  • Atara Biotherapeutics Inc
  • BioNTech SE
  • Endocyte Inc
  • Exelixis Inc
  • Juno Therapeutics Inc
  • Sollis Therapeutics Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sorrento Therapeutics Inc (Sorrento) is a biopharmaceutical company that focuses on developing therapeutics for the treatment of cancer, osteoarthritis pain and autoimmune diseases. The company’s immunotherapy pipeline portfolio comprises of a CD38 CAR-T, CD38 ADC, CD38 DAR-T and Sephrehvir for treatment of cancer. Sorrento is also investigating COVID19 programs which include Coviguard, Covidrops, Covishield among others for the treatment of COVID-19. Its marketed product include, ZTlido, a lidocaine topical system for the treatment of postherpetic neuralgia (PHN). The company works in collaboration with biopharmaceutical companies and academic institutions to develop novel immunotherapies. Sorrento is headquartered in San Diego, California, the US.

Sorrento Therapeutics Inc Key Recent Developments

Apr 05,2021: Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics
Mar 05,2021: Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
Feb 08,2021: Sorrento announces subsidiary company - ADNAB - to develop and commercialize ADNAB platform products for hematological malignancies and solid tumors based on an exclusive technology license from the Mayo Clinic
Oct 16,2020: Sorrento Therapeutics to purchase ACEA Therapeutics
Oct 09,2020: Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Atara Biotherapeutics Inc
  • BioNTech SE
  • Endocyte Inc
  • Exelixis Inc
  • Juno Therapeutics Inc
  • Sollis Therapeutics Inc
Section 1 - About the Company
  • Sorrento Therapeutics Inc - Key Facts
  • Sorrento Therapeutics Inc - Key Employees
  • Sorrento Therapeutics Inc - Key Employee Biographies
  • Sorrento Therapeutics Inc - Major Products and Services
  • Sorrento Therapeutics Inc - History
  • Sorrento Therapeutics Inc - Company Statement
  • Sorrento Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Sorrento Therapeutics Inc - Business Description
  • Business Segment: Scilex
  • Overview
  • Performance
  • Business Segment: Sorrento Therapeutics
  • Overview
  • Performance
  • R&D Overview
  • Sorrento Therapeutics Inc - Corporate Strategy
  • Sorrento Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Sorrento Therapeutics Inc - Strengths
  • Sorrento Therapeutics Inc - Weaknesses
  • Sorrento Therapeutics Inc - Opportunities
  • Sorrento Therapeutics Inc - Threats
  • Sorrento Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Sorrento Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 05, 2021: Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
  • Feb 08, 2021: Sorrento announces subsidiary company - ADNAB - to develop and commercialize ADNAB platform products for hematological malignancies and solid tumors based on an exclusive technology license from the Mayo Clinic
  • Oct 09, 2020: Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released
  • Oct 04, 2020: Sorrento to host a R&D day to showcase covid-19 product pipeline
  • Sep 28, 2020: Sorrento releases preclinical data for STI-1499 (COVI-Guard) and STI-2020 (COVI-AMG), potent neutralizing antibodies against SARS-CoV-2
  • Aug 21, 2020: Sorrento to merge with gene-encoded therapies firm SmartPharm
  • Aug 18, 2020: Sorrento Therapeutics : Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
  • Jun 12, 2020: Sorrento announces full repayment of outstanding term loans
  • May 11, 2020: Sorrento, Mount Sinai to develop antibody cocktail against Covid-19
  • Apr 30, 2020: Sorrento Therapeutics took $2-5 million PPP government loan for COVID-19-struck small businesses, FOIA request shows
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Sorrento Therapeutics Inc, Key Facts
  • Sorrento Therapeutics Inc, Key Employees
  • Sorrento Therapeutics Inc, Key Employee Biographies
  • Sorrento Therapeutics Inc, Major Products and Services
  • Sorrento Therapeutics Inc, History
  • Sorrento Therapeutics Inc, Subsidiaries
  • Sorrento Therapeutics Inc, Joint Venture
  • Sorrento Therapeutics Inc, Key Competitors
  • Sorrento Therapeutics Inc, Ratios based on current share price
  • Sorrento Therapeutics Inc, Annual Ratios
  • Sorrento Therapeutics Inc, Interim Ratios
  • Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Sorrento Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sorrento Therapeutics Inc, Performance Chart (2016 - 2020)
  • Sorrento Therapeutics Inc, Ratio Charts
  • Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Adaptimmune Therapeutics Plc
  • Sollis Therapeutics Inc
  • Endocyte Inc
  • BioNTech SE
  • Atara Biotherapeutics Inc
  • Exelixis Inc
  • Anthera Pharmaceuticals Inc
  • Par Pharmaceutical Holdings Inc
  • Juno Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll